MeadowBrook Investment Advisors LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

MeadowBrook Investment Advisors LLC purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 1,165 shares of the biopharmaceutical company’s stock, valued at approximately $94,000. A number of other hedge funds and other institutional investors have also recently added to or […]

Related Keywords

United States ,Complera Eviplera ,Merdad Parsey ,News Ratings For Gilead Sciences Daily ,Gilead Sciences Dividend Announcement ,Nasdaq ,Northern Trust Corp ,Gilead Sciences Inc ,Morgan Stanley ,Pacer Advisors Inc ,Cantor Fitzgerald ,Quarter For Gilead Sciences ,Gilead Sciences Company Profile ,Gilead Sciences ,Capital Management ,Associates Corp ,Meadowbrook Investment Advisors ,Gilead Sciences Stock ,Free Report ,Trust Corp ,Get Free Report ,Visit Holdingschannel ,Gilead Sciences Daily ,Nasdaq Gild ,Gild ,Medical ,37555810 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,